Research Area B
In Research Area B, based on the previously identified key drivers of transition, we will use both pharmacological and non-pharmacological approaches to prevent the progression towards clinical manifestations of autoimmune disease.
Details for each project are provided on the left.
- Projects
- 1st Generation
- 2nd Generation
- A: Defining Autoimmune Pre-Disease
- B: Targeting of Autoimmune Pre-Disease
- B4: Nutritional Treatments to Improve Inflammatory IgG Fc Glycosylation
- B5: Reversal of autoimmune pre-disease by weight loss
- B6: Modulation of T cell Receptor Repertoire in Autoimmunity after Treatment with Cell Derived Nanoparticles
- B7: Targeting IL-13 signaling pathway as a potential therapeutic approach in experimental models of pulmonary arterial hypertension.
- Associated projects
- MD projects
- Concluded projects
